AI Assistant
Blog
Pricing
Log In
Sign Up
P253 Transient versus sustained antibodies to infliximab: Possibility to overcome low titer antibody responses by dose optimisation
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
